These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36853114)

  • 1. Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus.
    Alkabab Y; Warkentin J; Cummins J; Katz B; Denison BM; Bartok A; Khalil A; Young LR; Timme E; Peloquin CA; Ashkin D; Houpt ER; Heysell SK
    Int J Tuberc Lung Dis; 2023 Feb; 27(2):135-139. PubMed ID: 36853114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring in the treatment of tuberculosis.
    Peloquin CA
    Drugs; 2002; 62(15):2169-83. PubMed ID: 12381217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early interventions for diabetes related tuberculosis associate with hastened sputum microbiological clearance in Virginia, USA.
    Alkabab Y; Keller S; Dodge D; Houpt E; Staley D; Heysell S
    BMC Infect Dis; 2017 Feb; 17(1):125. PubMed ID: 28166721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring in the treatment of active tuberculosis.
    Babalik A; Babalik A; Mannix S; Francis D; Menzies D
    Can Respir J; 2011; 18(4):225-9. PubMed ID: 22059181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring in the treatment of tuberculosis: an update.
    Alsultan A; Peloquin CA
    Drugs; 2014 Jun; 74(8):839-54. PubMed ID: 24846578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study.
    van den Elsen SH; Sturkenboom MG; Akkerman O; Barkane L; Bruchfeld J; Eather G; Heysell SK; Hurevich H; Kuksa L; Kunst H; Kuhlin J; Manika K; Moschos C; Mpagama SG; Muñoz Torrico M; Skrahina A; Sotgiu G; Tadolini M; Tiberi S; Volpato F; van der Werf TS; Wilson MR; Zúñiga J; Touw DJ; Migliori GB; Alffenaar JW
    BMJ Open; 2020 Jun; 10(6):e035350. PubMed ID: 32554740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia.
    Magee MJ; Kempker RR; Kipiani M; Tukvadze N; Howards PP; Narayan KM; Blumberg HM
    PLoS One; 2014; 9(4):e94890. PubMed ID: 24736471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study.
    Ghimire S; Karki S; Maharjan B; Kosterink JGW; Touw DJ; van der Werf TS; Shrestha B; Alffenaar JW
    BMJ Open Respir Res; 2020 Aug; 7(1):. PubMed ID: 32796020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TB therapeutic drug monitoring - analysis of opportunities in Romania and Ukraine.
    Margineanu I; Butnaru T; Gafar F; Baiceanu D; Dragomir R; Semianiv I; Mihaltan F; Munteanu I; Mahler B; Todoriko L; Margineanu S; Akkerman O; Stienstra Y; Alffenaar JC
    Int J Tuberc Lung Dis; 2023 Nov; 27(11):816-821. PubMed ID: 37880891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of bacteriological conversion and treatment outcomes among MDR-TB patients with and without diabetes in Mexico: Preliminary data.
    Muñoz-Torrico M; Caminero Luna J; Migliori GB; D'Ambrosio L; Carrillo-Alduenda JL; Villareal-Velarde H; Torres-Cruz A; Flores-Ergara H; Martínez-Mendoza D; García-Sancho C; Centis R; Salazar-Lezama MÁ; Pérez-Padilla R
    Rev Port Pneumol (2006); 2017; 23(1):27-30. PubMed ID: 28043788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of therapeutic drug monitoring for multidrug-resistant tuberculosis patients.
    Li J; Burzynski JN; Lee YA; Berg D; Driver CR; Ridzon R; Munsiff SS
    Chest; 2004 Dec; 126(6):1770-6. PubMed ID: 15596672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Diabetes Mellitus in Patients with Tuberculosis: A Prospective Cohort Study.
    Buasroung P; Petnak T; Liwtanakitpipat P; Kiertiburanakul S
    Int J Infect Dis; 2022 Mar; 116():374-379. PubMed ID: 35093530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus.
    Lee YJ; Han SK; Park JH; Lee JK; Kim DK; Chung HS; Heo EY
    Korean J Intern Med; 2018 Sep; 33(5):933-940. PubMed ID: 29540054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of serum isoniazid level on treatment outcomes among tuberculosis patients with slow response - A retrospective cohort study.
    Kim HW; Shin AY; Ha JH; Ahn JH; Kang HS; Kim JS
    J Infect Chemother; 2021 Nov; 27(11):1555-1561. PubMed ID: 34238662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis.
    Dooley KE; Tang T; Golub JE; Dorman SE; Cronin W
    Am J Trop Med Hyg; 2009 Apr; 80(4):634-9. PubMed ID: 19346391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Diabetes Mellitus on Tuberculosis Treatment Outcome and Adverse Reactions in Patients Receiving Directly Observed Treatment Strategy in India: A Prospective Study.
    Siddiqui AN; Khayyam KU; Sharma M
    Biomed Res Int; 2016; 2016():7273935. PubMed ID: 27642601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus is not a predictor of poor TB treatment outcomes.
    Baltas I; Sturdy A; Kavallieros K; McGregor A; Corrah T; John L; Cooke G; Whittington AM
    Int J Tuberc Lung Dis; 2023 Feb; 27(2):140-145. PubMed ID: 36853108
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems.
    Märtson AG; Burch G; Ghimire S; Alffenaar JC; Peloquin CA
    Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):23-39. PubMed ID: 33040625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision and personalized medicine and anti-TB treatment: Is TDM feasible for programmatic use?
    Alffenaar JC; Akkerman OW; Kim HY; Tiberi S; Migliori GB
    Int J Infect Dis; 2020 Mar; 92S():S5-S9. PubMed ID: 31996324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed diagnosis of tuberculosis in patients with diabetes mellitus co-morbidity and its associated factors in Zhejiang Province, China.
    Xiao W; Huang D; Li S; Zhou S; Wei X; Chen B; Zou G
    BMC Infect Dis; 2021 Mar; 21(1):272. PubMed ID: 33736610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.